INVO Fertility (IVF) Total Non-Current Liabilities (2021 - 2026)
INVO Fertility (IVF) posted quarterly Total Non-Current Liabilities of $9.3 million for Q1 2026, down 57.44% year-over-year from $21.9 million in Q1 2025, and down 26.49% quarter-over-quarter from $12.7 million in Q4 2025.
INVO Fertility (IVF) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
INVO Fertility (IVF) has reported Total Non-Current Liabilities for 6 consecutive years, with $9.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Non-Current Liabilities fell 57.44% year-over-year to $9.3 million; the TTM figure through Mar 2026 stood at $9.3 million (down 57.44% YoY), while the FY2025 annual figure was $12.7 million, down 40.24% from the prior year.
- Total Non-Current Liabilities eased to $9.3 million in Q1 2026 per IVF's latest filing, from $12.7 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $21.9 million in Q1 2025 and bottomed at $107374.0 in Q4 2022.
- Historically, Total Non-Current Liabilities has averaged $5.5 million across 5 years, with a median of $144267.0 in 2022.
- Annual changes were most pronounced in 2025 — Total Non-Current Liabilities jumped 17720.43% — and 2026, when it sank 57.44%.
- INVO Fertility's Total Non-Current Liabilities stood at $107374.0 in 2022, then rose by 14.61% to $123060.0 in 2023, then soared by 17163.7% to $21.2 million in 2024, then tumbled by 40.24% to $12.7 million in 2025, then slipped by 26.49% to $9.3 million in 2026.
- Business Quant data shows IVF's Total Non-Current Liabilities at $9.3 million in Q1 2026, $12.7 million in Q4 2025, and $12.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.10 Bn | 196.49 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.66 Bn | 123.18 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 119.49 Bn | 110.27 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 74.29 Bn | 73.75 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 52.00 Bn | 47.75 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.73 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.26 Bn | 22.94 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.22 Bn | 22.74 Bn | 684.20 Mn | 3.44 Bn |
| 10 | INVO Fertility | 2.29 Mn | 2.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.33 Mn |
| Dec 31, 2025 | 12.70 Mn |
| Sep 30, 2025 | 12.18 Mn |
| Jun 30, 2025 | 15.56 Mn |
| Mar 31, 2025 | 21.93 Mn |
| Dec 31, 2024 | 21.24 Mn |
| Sep 30, 2024 | 123,060.00 |
| Jun 30, 2024 | 123,060.00 |
| Mar 31, 2024 | 123,060.00 |
| Dec 31, 2023 | 123,060.00 |
| Sep 30, 2023 | 117,989.00 |
| Jun 30, 2023 | 121,773.00 |
| Mar 31, 2023 | 114,824.00 |
| Dec 31, 2022 | 107,374.00 |
| Sep 30, 2022 | 144,267.00 |
| Jun 30, 2022 | 146,585.00 |
| Mar 31, 2022 | 146,515.00 |
| Dec 31, 2021 | 142,321.00 |